Interestingly, we observed expression of HTPAP in 89 of 246 tumor samples (36.2%) with promoters II+III (promoter II, n = 194; promoter III, n = 52), whereas 168 of 274 cases (61.3%) with promoter I expressed HTPAP (p<0.001). Here, PLPP5 is linked to neoplasm.